Please Wait

Applying Filters...

Regulators are applying higher levels of scrutiny and manufacturers are looking ever more critically at a new drug development process largely conceived in an era of blockbusters. While innovation is being applied to solve the challenges of science and technology, successfully achieving regulatory approval and reimbursement demands even more - a REINVENTION of the development process, with new vitality applied to the integration of clinical and regulatory strategies that drive commercial succes